Does LORLATINIB Cause Oedema peripheral? 198 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 198 reports of Oedema peripheral have been filed in association with LORLATINIB (Lorbrena). This represents 3.6% of all adverse event reports for LORLATINIB.
198
Reports of Oedema peripheral with LORLATINIB
3.6%
of all LORLATINIB reports
29
Deaths
62
Hospitalizations
How Dangerous Is Oedema peripheral From LORLATINIB?
Of the 198 reports, 29 (14.6%) resulted in death, 62 (31.3%) required hospitalization, and 4 (2.0%) were considered life-threatening.
Is Oedema peripheral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LORLATINIB. However, 198 reports have been filed with the FAERS database.
What Other Side Effects Does LORLATINIB Cause?
Death (1,050)
Neoplasm progression (633)
Off label use (394)
Weight increased (306)
Hallucination (290)
Blood cholesterol increased (281)
Dyspnoea (223)
Oedema (195)
Fatigue (188)
Peripheral swelling (164)
What Other Drugs Cause Oedema peripheral?
AMBRISENTAN (2,959)
TREPROSTINIL (2,816)
ADALIMUMAB (2,356)
LENALIDOMIDE (2,298)
AMLODIPINE (2,076)
PREDNISONE (2,029)
METHOTREXATE (1,939)
MACITENTAN (1,932)
RITUXIMAB (1,698)
TOCILIZUMAB (1,574)
Which LORLATINIB Alternatives Have Lower Oedema peripheral Risk?
LORLATINIB vs LORMETAZEPAM
LORLATINIB vs LORNOXICAM
LORLATINIB vs LOSARTAN
LORLATINIB vs LOSARTAN\LOSARTAN
LORLATINIB vs LOTEPREDNOL ETABONATE